Following many controversies on hydroxychloroquine, the French government has solved: it is now longer authorized in France. For a while now, this medication was at the heart of controversies, especially because of its effectiveness. Only prescribed at the hospital to treat extreme cases of Covid-19, two new studies have declared it was useless. Following the results, Health Minister Olivier Véran decided to revise prescription regulations. Then the World Health Organization chose to halt chloroquine clinical trials.
A string of events that led the French government to revoke the derogatory decree allowing hydroxychloroquine to treat Covid-19, excluding clinical trials. This medication is banned after the Upper Public Health Council gave an unfavorable review that, this past Tuesday, “recommended not to use hydroxychloroquine to treat Covid-19”.
Chloroquine, also commercialized as Plaquénil in France, was already banned in the city to treat the virus. “France has been impacted by health tragedies related to the misuse of some medications” the Health Minister justified why he does not want it to happen again, all the more that risks related to hydroxychloroquine have been called out.
As for the Medical Products Agency (ANSM) announced they have launched a precautionary process to halt hydroxychloroquine clinical trials in patients infected by coronavirus.
